Export

EN
FR
Levofloxacin
Essential medicine status
General description
Levofloxacin is a fluoroquinolone antibiotic primary used to treat multi drug resistant tuberculosis (MDR-TB) as second line treatment. It is included in the WATCH Group of AWaRe as its use for treating common syndromes carries a high risk of selection of bacterial resistance.
INN
Levofloxacin
Medicine type
Chemical agent
Antibiotic groups
EML status history
Therapeutic equivalent for
Wikipedia
Recommendations
Section
Antituberculosis medicines
  • Oral > Solid: 250 mg tablet; 500 mg tablet; 750 mg tablet (EML)